The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oxaliplatin Market Research Report 2024
Synopsis
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
This report aims to provide a comprehensive presentation of the global market for Oxaliplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin.
Report Scope
The Oxaliplatin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaliplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaliplatin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Segment by Type
Mannitol
Glucose Solution
Lactose Solution
Others
Segment by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxaliplatin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
This report aims to provide a comprehensive presentation of the global market for Oxaliplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin.
Report Scope
The Oxaliplatin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oxaliplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaliplatin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Segment by Type
Mannitol
Glucose Solution
Lactose Solution
Others
Segment by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxaliplatin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2019-2030)
2.2 Oxaliplatin Growth Trends by Region
2.2.1 Global Oxaliplatin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oxaliplatin Historic Market Size by Region (2019-2024)
2.2.3 Oxaliplatin Forecasted Market Size by Region (2025-2030)
2.3 Oxaliplatin Market Dynamics
2.3.1 Oxaliplatin Industry Trends
2.3.2 Oxaliplatin Market Drivers
2.3.3 Oxaliplatin Market Challenges
2.3.4 Oxaliplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxaliplatin Players by Revenue
3.1.1 Global Top Oxaliplatin Players by Revenue (2019-2024)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2019-2024)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2023
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2019-2024)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2025-2030)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2019-2024)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oxaliplatin Market Size (2019-2030)
6.2 North America Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oxaliplatin Market Size by Country (2019-2024)
6.4 North America Oxaliplatin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size (2019-2030)
7.2 Europe Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oxaliplatin Market Size by Country (2019-2024)
7.4 Europe Oxaliplatin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size (2019-2030)
8.2 Asia-Pacific Oxaliplatin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oxaliplatin Market Size by Region (2019-2024)
8.4 Asia-Pacific Oxaliplatin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oxaliplatin Market Size (2019-2030)
9.2 Latin America Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oxaliplatin Market Size by Country (2019-2024)
9.4 Latin America Oxaliplatin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size (2019-2030)
10.2 Middle East & Africa Oxaliplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oxaliplatin Market Size by Country (2019-2024)
10.4 Middle East & Africa Oxaliplatin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Detail
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis Oxaliplatin Introduction
11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2019-2024)
11.1.5 Sanofi-Aventis Recent Development
11.2 Yakult honsha
11.2.1 Yakult honsha Company Detail
11.2.2 Yakult honsha Business Overview
11.2.3 Yakult honsha Oxaliplatin Introduction
11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2019-2024)
11.2.5 Yakult honsha Recent Development
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Company Detail
11.3.2 Dr Reddy's laboratories Business Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
11.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2019-2024)
11.3.5 Dr Reddy's laboratories Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Introduction
11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Oxaliplatin Introduction
11.5.4 Teva Revenue in Oxaliplatin Business (2019-2024)
11.5.5 Teva Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Oxaliplatin Introduction
11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2019-2024)
11.6.5 Fresenius Kabi Recent Development
11.7 Hospira
11.7.1 Hospira Company Detail
11.7.2 Hospira Business Overview
11.7.3 Hospira Oxaliplatin Introduction
11.7.4 Hospira Revenue in Oxaliplatin Business (2019-2024)
11.7.5 Hospira Recent Development
11.8 Mylan
11.8.1 Mylan Company Detail
11.8.2 Mylan Business Overview
11.8.3 Mylan Oxaliplatin Introduction
11.8.4 Mylan Revenue in Oxaliplatin Business (2019-2024)
11.8.5 Mylan Recent Development
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Detail
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2019-2024)
11.9.5 Jiangsu Hengrui Medicine Recent Development
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Company Detail
11.10.2 Nanjing Pharmaceutical Factory Business Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2019-2024)
11.10.5 Nanjing Pharmaceutical Factory Recent Development
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Company Detail
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Detail
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.12.5 Qilu Pharmaceutical Recent Development
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Company Detail
11.13.2 Hisun Pharmaceutical Business Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.13.5 Hisun Pharmaceutical Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Detail
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.14.5 Lunan Pharmaceutical Recent Development
11.15 Luoxin
11.15.1 Luoxin Company Detail
11.15.2 Luoxin Business Overview
11.15.3 Luoxin Oxaliplatin Introduction
11.15.4 Luoxin Revenue in Oxaliplatin Business (2019-2024)
11.15.5 Luoxin Recent Development
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Company Detail
11.16.2 Halfsky Pharmacy Business Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Introduction
11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2019-2024)
11.16.5 Halfsky Pharmacy Recent Development
11.17 YRPG
11.17.1 YRPG Company Detail
11.17.2 YRPG Business Overview
11.17.3 YRPG Oxaliplatin Introduction
11.17.4 YRPG Revenue in Oxaliplatin Business (2019-2024)
11.17.5 YRPG Recent Development
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Company Detail
11.18.2 Hainan Jinrui Pharmaceutical Business Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.18.5 Hainan Jinrui Pharmaceutical Recent Development
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Company Detail
11.19.2 Jari Pharmaceutical Business Overview
11.19.3 Jari Pharmaceutical Oxaliplatin Introduction
11.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2019-2024)
11.19.5 Jari Pharmaceutical Recent Development
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Company Detail
11.20.2 Chiatai Tianqing Business Overview
11.20.3 Chiatai Tianqing Oxaliplatin Introduction
11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2019-2024)
11.20.5 Chiatai Tianqing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
